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The Russian Federation has among the highest rates of cardiovascular disease (CVD) in
the world and a high rate of untreated hypertension remains an important risk factor. Under-
standing who is at greatest risk is important to inform approaches to primary prevention.
Methods
2,353 hypertensive 35–69 year olds were selected from a population-based study, Know
Your Heart, conducted in Arkhangelsk and Novosibirsk, Russian Federation, 2015–2018.
The associations between untreated hypertension and a range of co-variates related to
socio-demographics, health, and health behaviours were examined.
Results
The age-standardised prevalence of untreated hypertension was 51.1% (95% CI 47.8–
54.5) in males, 28.8% (25.4–32.5) in females, and 40.0% (37.5–42.5) overall. The factors
associated with untreated hypertension relative to treated hypertension were younger ages,
self-rated general health as very good-excellent, not being obese, no history of CVD events,
no evidence of diabetes or chronic kidney disease, and not seeing a primary care doctor in
the past year as well as problem drinking for women and working full time, lower education,
and smoking for men.
Conclusion
The study found relatively high prevalence of untreated hypertension, especially, in men.
Recent initiatives to strengthen primary care provision and implementation of a general
health check programme (dispansarisation) are promising, although further studies should
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Introduction
Once detected, hypertension is relatively easy to treat, thereby reducing markedly the risk of
complications. Yet many people live for a long time unaware that they have it. A first step in
addressing this problem is to determine who, within a population, are most likely to have
hypertension that is undetected and untreated. This has been addressed in many populations
by studies of the closely associated reasons for non-attendance at general health checks and
non-adherence to prescription drugs. These studies point to the importance of knowledge,
time, resources, social support, certain beliefs, capability, opportunity, and motivation at the
level of the individual and investment in education, healthcare technologies, and healthcare
systems at a societal level. Policy responses often focus on the latter, for example through mea-
sures to encourage health workers to identify and treat hypertension and to ensure reliable
supplies of medicines. Yet, even when well-functioning health systems exist, if those involved
fail to recognise the burden on the individual who must change their health seeking and main-
taining behaviours to avoid cardiovascular disease (CVD) then failure is likely [1,2]. This
makes it necessary to understand the complex barriers and facilitators to diagnosis and treat-
ment and how they vary within populations, and especially those groups that are hard-to-
reach.
Studies of non-attendance at general health checks found that those most likely to miss out
include the less well educated, less affluent, younger, males, lacking social support, struggling
to overcome barriers in terms of geographical and physical access, perceiving themselves not
at risk, not yet having a CVD, or smokers [3,4]. Studies of non-adherence to prescription
drugs are similar, but also list forgetfulness [5] and factors related to therapy such as adverse
drug reactions, prescription error, ineffective and counterfeit drugs, drugs not perceived effec-
tive, prescription costs, cumbersome refill prescription systems, beliefs in supplements and
alternative remedies lacking scientifically proven efficacy or safety records [6].
In this paper we look at factors associated with untreated hypertension in Russian 35–69
year olds. Russia has very high CVD mortality compared to countries at similar levels of eco-
nomic development and untreated hypertension is a persisting and important challenge to
CVD prevention even though the Russian primary care system is free at the point of use. It has
also established a programme of general health checks, offered to the entire adult population,
called dispansarisation. This has been expanded progressively since 2013 [7–11].
The aims of the study were to determine the prevalence of untreated hypertension in popu-
lation samples of two Russian cities, Arkhangelsk and Novosibirsk, and to identify factors asso-
ciated with untreated hypertension in these two populations.
Materials and methods
Population sample
In this study we used data from the Know Your Heart (KYH), a cross-sectional study of car-
diovascular structure, function and risk factors in over 4,500 men and women aged 35–69
years from two Russian cities, Arkhangelsk and Novosibirsk, in 2015–2018 [12]. In brief, the
study was conducted in three stages: 1) background interview; 2) health check; 3) repeat health
check. A list of residential addresses was drawn at random from a population list stratified by
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age, sex, district, and city. Trained interviewers visited the addresses and conducted the base-
line interview. At the interview, respondents were invited to take part in a health check in a
local polyclinic, which included blood pressure measurements. Finally, a stratified random
sample of respondents were invited back a year later for a repeat health check. Response rates
for the health check component in KYH was 51% in Arkhangelsk and 22% in Novosibirsk
based on denominators excluding addresses not found and addresses without at least one per-
son of expected age and gender [12]. 2,353 participants were selected for this study, based on
the following inclusion criteria: aged 35–69 years, recorded systolic and diastolic blood pres-
sure, hypertension (blood pressure at or above 140/90 mmHg) or taking antihypertensive
medication.
Screening examination
Blood pressure was measured in KYH using OMRON 705 IT automatic blood pressure moni-
tors (OMRON Healthcare). All devices were calibrated before and after the fieldwork period
and no adjustments were needed.
Participants were assigned to different antihypertensive classes based on their systolic and
diastolic blood pressure (average of last two out of three measurements) according to the Euro-
pean hypertension treatment guidelines [13] and antihypertensive use. The thresholds for
hypertension were a systolic pressure of 140 mmHg or more and/or a diastolic of 90 mmHg or
more (office measurement) [13]. Antihypertensive medications were self-reported and com-
prised those falling within the WHO Anatomical Therapeutic Chemical (ATC) [14] classifica-
tion system ATC classes, C02, C03, C07, C08, or C09. The main analyses were based on ATC
code alone. Sensitivity analyses were conducted using self-reported use of antihypertensive
(irrespective of whether a relevant medication was identified among the ATC codes).
To address measurement error (biological variability and measurement method) a random
sample of participants stratified by age and sex were invited back a year later for a repeated
measurement. The distribution of those who attended the repeated measurement (N = 332)
versus those who did not (N = 3,770) is shown in S3 Table. The sample for this part of the
study was larger and included all participants and not only those found to have hypertension.
To estimate measurement error, only data from participants not on antihypertensive medica-
tions and with blood pressures in the normal range (systolic <140 mmHg; diastolic <90
mmHg) at both visits were selected to exclude those that were informed by the study that their
blood pressure was too high at the first visit as well as those on treatment. Standard deviation
within subjects and within-subject coefficients of variance were calculated [15]. The prevalence
of different hypertension status outcomes at the second measurement were calculated and
standardised to 2013 European Standard Population for those who were initially found with
untreated hypertension.
Definition of risk factors
Level of education was categorised into four groups: elementary (incomplete secondary, pro-
fessional no secondary), lower intermediate (complete secondary, professional and secondary),
higher intermediate (specialised secondary, incomplete higher), graduate. Self-perceived
financial constraints were categorized as: household perceived to be constrained in buying
food or clothes versus constrained in buying large domestic appliances versus unconstrained
in buying any of the above. Single status was defined as anyone not living with a partner. Self-
reported alcohol consumption and alcohol-related behaviours were used to create three cate-
gories: Non-drinker past year versus low risk drinkers (score<8) versus high risk drinkers
(score 8+) according to WHO alcohol use disorder screening tool [16]. Physical activity was
PLOS ONE Untreated hypertension in Russian 35-69 year olds
PLOS ONE | https://doi.org/10.1371/journal.pone.0233801 May 29, 2020 3 / 12
measured employing the Total physical activity index using the standard classification of inac-
tive versus moderately inactive, moderately active, and active [17]. Diabetes status was ascer-
tained on either self-reported diabetes, self-reported diabetes medication use (ATC A10:
insulin or oral antidiabetics) or HbA1c 48+ mmol/mol (>6.5%) [18]. Chronic kidney disease
(CKD) status was defined as Glomerular Filtration Rate (eGFR) below 60ml/min/1.73m2
based on serum creatinine [19]. A variable for CVD history comprised any self-reported his-
tory of myocardial infarction, heart failure, atrial fibrillation, angina, or stroke events. The
presence of depression was included in the analyses because it has been associated with CVD
mortality, and specifically in Eastern European countries [20]. Here it was defined as having a
score at and above 5 on the PHQ-9 instrument [21]. Attendance at a general health check was
ascertained using a question about having attended the dispansarisation programme since its
relaunch in 2013; this was used in the descriptive analysis [7]. Economic activity was defined
according to responses to routed questions on retirement (baseline questionnaire item A11),
regular paid work (A12), and other activity (A14). Hypertension knowledge was tested with a
question about whether hypertension is believed to always, sometimes, or never be associated
with symptoms.
Statistical analysis
The prevalence of untreated hypertension was estimated and standardized by age and sex to
the European Standard Population [22]. Gender-specific multivariate logistic regression mod-
els of untreated versus treated hypertension in 35–69 year olds adjusting for age or age and
CVD history were fitted using Stata 15 [23]. A range of co-variates was included as potential
factors associated with untreated hypertension, i.e. education, marital status, body mass index,
alcohol consumption, depression (PHQ-9), and whether a primary care doctor was visited in
the past year.
Ethical approval
The study complied with the 1964 Helsinki declaration and its later amendments and ethical
approval was received from the ethics committees of London School of Hygiene and Tropical
Medicine (approval number 8808), Novosibirsk State Medical University (approval number
75; 21 May 2015), the Institute of Preventative Medicine (approval received 26 December
2014), Novosibirsk and the Northern State Medical University, Arkhangelsk (approval number
01/01-15; 27 January 2015). Informed written consent was obtained from all individual partici-
pants included in the study.
Results
The characteristics of the study participants (N = 2,353) are shown in S1 and S2 Tables. The
prevalence by gender of the different hypertensive categories, including normotensives, can be
found at Fig 1.
To address measurement error, a random sample of 332 participants (178 females and 154
males) were invited back a year later for a repeated measurement (Fig 2). 109 participants, nor-
motensive at both visits, were selected. The mean duration between the two measurements
was 359 days (SD 22). Standard deviation within subjects were 5.8 mmHg and 3.5 mmHg for
systolic and diastolic measurements, respectively. The within-subject coefficients of variance
for the same measurements were 5.0% and 4.6%.
For those in the repeated measurement sub-sample (N = 332) found to have untreated
hypertension at the first visit, the most common trajectory for men was to be classified as hav-
ing untreated hypertension again (55%; 95% CI 42–68) and only 17% (9–30) were on
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antihypertensive medications a year later. For women, the same proportions were 37% (22–
54) and 37% (22–54).
The prevalence of untreated hypertension among those with hypertension was 51.1% (95%
CI 47.8–54.5) for males, 28.8% (25.4–32.5) for females, and 40.0% (37.5–42.5) overall (S3
Table).
The factors associated with untreated hypertension relative to treated hypertension were
younger ages, self-rated general health as very good-excellent, not being obese, no history of
CVD events, no evidence of diabetes or CKD, and not seeing a primary care doctor in the past
year as well as problem drinking for women and working full time, lower education, and
smoking for men (Tables 1 and 2). These effects held even when, in addition, adjusting for
CVD history.
For women, hypertension awareness was 85% among those with treated hypertension and
40% among those untreated (S1 Table). For men, the same proportions were similar, 85% and
38%, respectively (S2 Table).
For women, general health check attendance was 57% in those with untreated hypertension
and 50% in those with treated hypertension (S1 Table). For men, 33% and 29% (S2 Table).
Fig 1. Age-standardised prevalence (%) of hypertensive categories among 35–69 year olds by gender.
https://doi.org/10.1371/journal.pone.0233801.g001
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The majority of respondents was unaware that hypertension was an asymptomatic condi-
tion (S1 and S2 Tables). The most ‘knowledgeable’ were untreated men (17% of men knew the
correct answer) and the least were treated women (8%).
Discussion
Prevalence of untreated hypertension among the 35–69 year olds in this study was 51% in
males, 29% in females, and 40% overall. Similar levels were found in the concurrent ESSE-RF
Study carried out in a population-based sample of 25–64 year olds in four other Russian
regions, i.e. 58% in men, 29% in women, and 47% overall [24]. In comparison, a study with
data from 123 nationally representative surveys of 40–79 year olds in 12 high income countries
[25] found that prevalence of untreated hypertension in males ranged from 19% in Canada to
61% in Ireland. For females, from 20% in Germany and the US to 50% in Ireland. The KYH
study population would therefore fall into the mid-range for males and towards the best per-
forming end for females. The prevalence in males was on par with Italy (44%), Australia
(45%), Finland (45%), New Zealand (45%), UK (45%), Japan (48%), and Spain (49%). For
women, it was on par with South Korea (26%), Germany (20%), and the US (20%). Common
to the best performing countries, were that national clinical guidelines recommend treatment
of blood pressures at and above 140/90 mmHg and a working general health check pro-
gramme. Russian health professionals should follow European treatment guidelines, initiating
treatment at blood pressures at and above 140/90 mmHg. The dispansarisation programme,
expanded in 2013, is central to preventive efforts. At the time of data collection, in 2015–2018,
among those with untreated hypertension 50% of women and 30% of men had attended a gen-
eral health check since 2013 versus 57%/33% among those with treated hypertension. This
indicates that the dispansarisation programme still has some way to go in terms of coverage. It
should be noted that legislation enacted in 2019 aims to strengthen the dispansarisation
Fig 2. Hypertension status flows between first and repeated measurement for a subset of female (left panel; N = 178) and male (right; N = 154) 35–69 year olds.
https://doi.org/10.1371/journal.pone.0233801.g002
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programme further by offering it yearly to those aged 40 years and above, introducing an
online appointment system for users and opening evening and Saturday appointments [11].
Table 1. Logistic regression models of untreated versus treated hypertension among female participants (N = 1,265).
Characteristic Level AOR age P-value 95% CI AOR age/CVD P-value 95% CI
CVD history No Ref
Yes 0.26 < .001 0.18–0.38
Age group 35–49 yr Ref Ref
50–59 yr 0.58 .003 0.41–0.83 0.67 .031 0.46–0.96
60–69 yr 0.33 < .001 0.23–0.47 0.46 < .001 0.32–0.66
Education Elementary Ref Ref
Lower intermediate 1.35 .397 0.67–2.72 1.47 .290 0.72–2.99
Higher intermediate 1.38 .329 0.72–2.65 1.48 .244 0.76–2.87
Graduate 1.63 .148 0.84–3.17 1.63 .157 0.83–3.20
Economic activity Retired Ref Ref
Paid work 1.57 .073 0.96–2.57 1.45 .137 0.89–2.38
Looking after home 0.91 .701 0.58–1.44 0.95 .818 0.59–1.51
Unemployed 0.78 .711 0.20–2.97 0.82 .780 0.21–3.23
Other 2.16 .326 0.46–10.1 2.43 .276 0.49–12.0
Household income Constrained Ref Ref
Intermediary 0.90 .543 0.64–1.26 0.83 .304 0.59–1.18
Rel. unconstrained 1.12 .555 0.76–1.66 1.00 .976 0.68–1.50
Single No Ref Ref
Yes 0.85 .265 0.65–1.13 0.92 .566 0.69–1.22
Smoking No Ref Ref
Yes 1.21 .312 0.84–1.74 1.23 .270 0.85–1.79
Alcohol use disorder Non-drinker past year Ref Ref
Low (AUDIT<8) 1.15 .494 0.77–1.72 1.09 .684 0.72–1.64
High (AUDIT 8+) 3.55 .002 1.61–7.84 3.04 .007 1.36–6.77
Physical activity Inactive Ref Ref
Moderately inactive 1.34 .446 0.63–2.83 1.49 .306 0.70–3.18
Moderately active 1.25 .500 0.65–2.40 1.39 .328 0.72–2.67
Active 1.08 .816 0.54–2.16 1.15 .697 0.57–2.30
Self-rated general health Poor/fair/good Ref Ref
Very good/excellent 2.20 < .001 1.65–2.94 1.97 < .001 1.47–2.64
Body Mass Index Under/Normal (<25) Ref Ref
Overweight (25–29) 1.00 .988 0.67–1.47 0.95 .800 0.64–1.41
Obese (30–34) 0.60 .015 0.40–0.91 0.60 .019 0.40–0.92
Very obese (35+) 0.35 < .001 0.21–0.58 0.35 < .001 0.21–0.58
Diabetic No Ref Ref
Yes 0.36 < .001 0.22–0.59 0.38 < .001 0.23–0.63
CKD No Ref Ref
Yes 0.65 .187 0.35–1.23 0.70 .284 0.37–1.34
Depression (PHQ-9) No Ref Ref
Yes 0.67 .006 0.51–0.89 0.76 .060 0.57–1.01
Seen primary care doctor past year No Ref Ref
Yes 0.29 < .001 0.21–0.39 0.32 < .001 0.23–0.43
Age- and CVD history-adjusted odds ratios (AOR) with 95% confidence intervals.
https://doi.org/10.1371/journal.pone.0233801.t001
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Untreated hypertension was found to be associated with younger ages, self-rated general
health as very good-excellent, not being obese, no history of CVD events, no evidence of
Table 2. Logistic regression models of untreated versus treated hypertension among male participants (N = 1,088).
Characteristic Level AOR age P-value 95% CI AOR age/CVD P-value 95% CI
CVD history No Ref
Yes 0.23 < .001 0.17–0.32
Age group 35–49 yr Ref Ref
50–59 yr 0.48 < .001 0.35–0.67 0.57 .002 0.40–0.81
60–69 yr 0.29 < .001 0.21–0.40 0.41 < .001 0.30–0.58
Education Elementary Ref Ref
Lower intermediate 0.68 .104 0.42–1.08 0.62 .062 0.38–1.02
Higher intermediate 0.65 .061 0.42–1.02 0.59 .032 0.37–0.96
Graduate 0.59 .022 0.38–0.93 0.50 .004 0.31–0.81
Economic activity Retired Ref Ref
Paid work 1.92 .001 1.31–2.81 1.64 .014 1.10–2.45
Looking after home 1.05 .895 0.52–2.12 1.16 .694 0.55–2.45
Unemployed 1.99 .083 0.91–4.33 2.22 .057 0.98–5.04
Other 1.33 .486 0.60–2.95 1.25 .604 0.54–2.85
Household income Constrained Ref
Intermediary 1.04 .819 0.74–1.46 0.88 .497 0.62–1.26
Rel. unconstrained 1.13 .522 0.78–1.62 0.84 .376 0.57–1.23
Single No Ref Ref
Yes 1.40 .056 0.99–1.98 1.40 .068 0.98–2.00
Smoking No Ref Ref
Yes 1.39 .012 1.07–1.80 1.43 .010 1.09–1.87
Alcohol use disorder Non-drinker past year Ref Ref
Low (AUDIT<8) 1.21 .198 0.90–1.63 1.13 .435 0.83–1.54
High (AUDIT 8+) 1.33 .073 0.97–1.82 1.17 .342 0.85–1.63
Physical activity Inactive Ref Ref
Moderately inactive 0.60 .148 0.30–1.20 0.64 .223 0.31–1.31
Moderately active 0.67 .199 0.36–1.23 0.70 .266 0.37–1.32
Active 1.05 .886 0.56–1.96 1.02 .944 0.53–1.96
Self-rated general health Poor/fair/good Ref Ref
Very good/excellent 2.18 < .001 1.69–2.81 1.77 < .001 1.35–2.30
Body Mass Index Under/Normal (<25) Ref Ref
Overweight (25–29) 0.58 .001 0.42–0.80 0.58 .002 0.41–0.81
Obese (30–34) 0.32 < .001 0.22–0.47 0.31 < .001 0.21–0.47
Very obese (35+) 0.20 < .001 0.11–0.35 0.22 < .001 0.12–0.40
Diabetic No Ref Ref
Yes 0.26 < .001 0.16–0.41 0.30 < .001 0.19–0.49
CKD No Ref Ref
Yes 0.35 .007 0.17–0.75 0.44 .040 0.20–0.96
Depression (PHQ-9) No Ref Ref
Yes 0.69 .011 0.52–0.92 0.86 .337 0.64–1.17
Seen primary care doctor past year No Ref Ref
Yes 0.35 < .001 0.27–0.46 0.39 < .001 0.30–0.51
Age- and CVD history-adjusted odds ratios (AOR) with 95% confidence intervals.
https://doi.org/10.1371/journal.pone.0233801.t002
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diabetes or CKD, and not seeing a primary care doctor in the past year as well as problem
drinking for women and working full time, lower education, and smoking for men.
These findings are largely consistent with the literature on non-attendance to participatory
health interventions and drug non-adherence [3,4,6,26], although financial constraints were
not found statistically significant or important. The ESSE-RF Study in Russia found younger
ages and absence of CVD associated with untreated hypertension [24]. Other factors were
rural residence and higher lipids in men and higher heart rates in women.
Interestingly, working full time for men was associated with untreated hypertension even
after adjusting for age and CVD history. This suggests that not having sufficient time to navi-
gate the healthcare system to get a health check and appropriate treatment could be a barrier,
especially, for men. This finding points to a need to undertake more studies on how to lower
the barriers for full time workers. To this end, under legislation enacted in 2018, workers are
now entitled to paid leave when attending the dispansarisation health checks [27].
Of those with untreated hypertension, as many as 40% of women and 38% of men reported
to have been diagnosed with hypertension at some point (hypertension awareness). Only 14%
of women with untreated hypertension and 17% of men knew that hypertension was an
asymptomatic condition. A study of first time attenders to a cardiology clinic in Moscow with
six month follow-up similarly found absence of symptoms (73%) to be the most common rea-
son given for non-adherence [5]. Less commonly given reasons were forgetfulness (31%), out-
of-pockets costs (22%), non-eligibility of re-imbursement schemes (14%), side-effects (10%),
treatment courses (7%), and polypharmacy (5%). This points to particular issues around health
knowledge and medication adherence that should be studied further. Other studies have
found the misconception that hypertension is a condition brought on temporarily by stress
and that antihypertensive medications no longer need be taken if the feelings of stress pass
[28].
For those with untreated hypertension at the first visit, the most common trajectory for
men was to be diagnosed with untreated hypertension again (55%; 95% CI 42–68), 17% were
on antihypertensive medications (9–30), and only 3.7% (0.9–14) with controlled hypertension
a year later. For women, the same proportions were 37% (22–54), 37% (22–55), and 34% (19–
53) (Fig 1). Although these findings were based on a very small number of participants, they
do suggest that women are more likely than men to act upon health advice when informed
about a preventable health issue such as untreated hypertension. This finding could inform
encounters in general practice when prompting patients to take part in health checks as well as
in public health campaigns tailored to male audiences.
Detection, treatment, and control of hypertension have improved internationally since the
1980s in high-income countries, yet control has stagnated since the mid- to late 2000s, point-
ing to a need for innovative strategies or interventions should be considered in addition to the
existing measures. New interventions may exploit new technologies [25], raise awareness
through large pragmatic studies such as the May Measurement Month project [29] where par-
ticipants can contribute to international research, or explore new effective settings for outreach
such as the example of the Los Angeles black barbershop trial [30]. At a more strategic level,
there are examples of interventions that have achieved good results by offering comprehensive
and contextualised care involving networks of non-physician health workers [31]. A recent
review of the effectiveness of blood pressure control strategies with 100 articles concluded that
multilevel, multicomponent strategies followed by patient-level strategies were the most effi-
cient [32]. Examples of effective strategies included team-based care strategies and strategies
providing training for home monitory of blood pressure and health coaching in primary care
and community settings. The review also concluded that trial evidence on strategies involving
electronic decision support systems is still sparse and should be evaluated further.
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Limitations
Sampling bias introduced by non-response was assessed by comparing the realised sample
against data from the Russian Census 2010 on age, gender, and higher education attainment
[12]. Overall, the realised sample for the health check was close to equity, with a ratio of 0.99
(95% CI 0.93–1.06) for Arkhangelsk and 1.26 (1.17–1.34) for Novosibirsk. It cannot be
excluded that non-responders could have been less likely to seek healthcare and adhere to
medical advice than responders. Among those that did not attend the health check, there were
relatively fewer with CVD and hypertension awareness at the baseline compared to those that
did attend [12]. The true prevalence of untreated hypertension is therefore likely to be even
higher than estimated in this study.
In addition to non-response biases, the study will by design have excluded institutionalised
individuals, individuals with no fixed abode, and individuals too ill to be interviewed or to take
part in the health check carried out at a local clinic, and as such may not be fully representative
of groups that currently are hard to reach with public health interventions. This is a limitation
that should be borne in mind when interpreting the results of the study.
The definition of hypertension used in this study relied on a precise measurement of blood
pressure at a single time point. If there were a large measurement error associated with blood
pressure measurement either due to biological variability or measurement method, this could
affect the outcome variable and potentially dilute the purported associations with risk factors
[33]. The within-individual standard variation was found to be relatively modest among indi-
viduals measured again a year later. Only individuals normotensive at both visits were
included in this part of the study to, as far as possible, exclude factors associated with treatment
as well as those who prompted by the results of the first visit could have sought further care or
ameliorated their health behaviours accordingly.
Identification of those treated for hypertension was based on self-reported medication data
but not every participant may have been aware of the indication for each medicine reported.
As a sensitivity analysis, prevalence of untreated hypertension was calculated using a question
on whether antihypertensive medications were taken, with similar results.
Conclusion
The study found a relatively high prevalence of untreated hypertension, especially, in men. Ini-
tiatives to strengthen the primary care provision and the dispansarisation general health check
programme making it yearly for those aged 40 years and above, extending hours, introducing
Saturday appointments as well as paid leave for those in full time work to attend are promising.
Further studies should however investigate whether more effective strategies could be designed
to accommodate population needs in terms of detection and adherence to antihypertensive
medications.
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